封面
市场调查报告书
商品编码
1634167

全球肾结石取出设备市场 - 2025 - 2033

Global Kidney Stone Retrieval Devices Market - 2025 - 2033

出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2023年,全球肾结石取出设备市场规模达26.7亿美元,预估至2033年将达43.0亿美元,2025-2033年预测期间复合年增长率为4.8%。

肾结石疾病,也称为肾结石,是一种常见的泌尿系统疾病,涉及肾臟中的矿物质和盐晶体。治疗涉及专门的医疗设备,如 ESWL、输尿管镜、PCNL 仪器和先进的成像系统。科技进步促进了微创、高效设备的发展,这些设备可以改善患者的治疗效果并缩短復原时间。肾结石疾病的日益普及和对非侵入性治疗的需求继续推动该医疗设备领域的创新。

市场动态:

驱动程式和限制

肾结石盛行率上升

由于影响全球 10-15% 人口的肾结石疾病盛行率不断上升,全球肾结石取出设备市场正在持续成长。不健康的饮食、肥胖、脱水和久坐的生活方式等因素导致肾结石发病率激增。这就产生了对输尿管镜、碎石器和取石篮等有效、微创解决方案的需求。人们对早期诊断和先进治疗方案的认识不断提高,鼓励更多患者寻求医疗干预,进一步推动市场成长。以患者为中心的创新检索设备的需求预计将呈指数级增长,为製造商和医疗保健提供者带来重大机会。

例如,每年每 500 名美国人中就有 1 人患有肾结石,其中八分之一的男性和十六分之一的女性在一生中会患上这种疾病。 2000年,近20亿美元用于管理和照护结石疾病患者,费用逐年增加。由于气候变暖导致出汗增加、体液流失和尿量减少,肾结石在美国东南部的发生率是美国东南部的两倍。

缺乏熟练的专业人员

由于缺乏接受先进检索技术培训的熟练专业人员,全球肾结石检索设备市场面临重大挑战。在发展中和欠发达地区,泌尿科医生和专业医疗保健提供者的短缺限制了输尿管镜检查、雷射碎石术和机器人辅助干预等先进治疗方案的采用。缺乏足够的培训计划和研讨会进一步加剧了这个问题。透过有针对性的培训计划、国际合作和医学教育投资来解决这一技能差距可能有助于弥合这一差距并提高市场渗透率。

有关此报告的更多详细资讯 - 索取样品

目录

第 1 章:方法与范围

第 2 章:定义与概述

第 3 章:执行摘要

第 4 章:动力学

  • 影响因素
    • 司机
      • 肾结石盛行率上升
    • 限制
      • 缺乏熟练的专业人员
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章:依产品类型

  • 碎石机
  • 输尿管镜
  • 石头清除篮
  • 取石钳
  • 支架

第 7 章:按治疗类型

  • 体外震波碎石术
  • 经皮肾镜碎石术
  • 体内输尿管镜检查

第 8 章:最终用户

  • 医院
  • 门诊手术中心 (ASC)
  • 专科诊所

第 9 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 11 章:公司简介

  • Boston Scientific Corporation
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Olympus Corporation
  • Becton, Dickinson and Company
  • Cook Medical
  • Coloplast Group
  • Dornier MedTech
  • Storz Medical AG
  • CR Bard Inc
  • Stryker Corporation
  • Karl Storz SE & Co. KG

第 12 章:附录

简介目录
Product Code: MD8531

The global kidney stone retrieval devices market reached US$ 2.67 billion in 2023 and is expected to reach US$ 4.30 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2025-2033.

Kidney stone disease, also known as nephrolithiasis, is a common urological condition involving mineral and salt crystals in the kidneys. Treatment involves specialized medical devices like ESWL, ureteroscopes, PCNL instruments, and advanced imaging systems. Technological advancements have led to the development of minimally invasive, highly effective devices that improve patient outcomes and reduce recovery times. The increasing prevalence of kidney stone disease and demand for non-invasive treatments continue to drive innovation in this medical device segment.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Kidney Stone Disease

The global kidney stone retrieval devices market is growing due to the increasing prevalence of kidney stone disease, which affects 10-15% of the global population. Factors like unhealthy diets, obesity, dehydration, and sedentary lifestyles contribute to the surge in kidney stone incidence. This has created a demand for effective, minimally invasive solutions like ureteroscopes, lithotripters, and stone retrieval baskets. The increasing awareness of early diagnosis and advanced treatment options has encouraged more patients to seek medical intervention, further boosting market growth. The demand for innovative, patient-centric retrieval devices is expected to grow exponentially, presenting significant opportunities for manufacturers and healthcare providers.

For instance, Kidney stone disease affects one in every 500 US individuals each year, with 1 in 8 men and 1 in 16 women developing the disease over their lifetime. In 2000, nearly $2 billion was spent on managing and caring for patients with stone disease, with the cost increasing annually. Nephrolithiasis is twice as common in the southeastern US due to warmer climates causing increased sweating, fluid loss, and lowered urine output.

Lack of Skilled Professionals

The global kidney stone retrieval devices market faces a significant challenge due to the lack of skilled professionals trained in advanced retrieval technologies. In developing and underdeveloped regions, the shortage of urologists and specialized healthcare providers limits the adoption of advanced treatment options like ureteroscopy, laser lithotripsy, and robotic-assisted interventions. The lack of adequate training programs and workshops further exacerbates the issue. Addressing this skill gap through targeted training initiatives, international collaborations, and investments in medical education could help bridge this gap and improve market penetration.

Segment Analysis

The global kidney stone retrieval devices market is segmented based on product type, treatment type, end user and region.

Product Type:

Lithotripters segment is expected to dominate the Kidney Stone Retrieval Devices market share

The lithotripters segment holds a major portion of the kidney stone retrieval devices market share and is expected to continue to hold a significant portion of the kidney stone retrieval devices market share during the forecast period.

Lithotripters are a crucial part of the global kidney stone retrieval devices market, used to treat kidney stones without invasive procedures. They use energy sources like shock waves, ultrasound, or lasers to break down kidney stones into smaller pieces, which can be naturally excreted or removed. Extracorporeal shock wave lithotripsy (ESWL) is popular due to its non-invasive nature and high success rates. Advanced laser lithotripters, like those used in ureteroscopy, offer precise stone fragmentation for complex or larger stones. Moreover, technological advancements, like AI for stone targeting and energy optimization, are expected to further enhance their market role.

For instance, in September 2024, according to a clinical trial in The Journal of Urology found that Break Wave lithotripsy (BWL) is a noninvasive ultrasound technology which offers a safe and effective treatment option for urinary stones,. The technology, which can be used in various settings without the need for anesthesia, has shown a high treatment success rate in its initial experience.

End User:

Hospitals segment is the fastest-growing segment in Kidney Stone Retrieval Devices market share

The hospitals segment is the fastest-growing segment in the kidney stone retrieval devices market share and is expected to hold the market share over the forecast period.

Hospitals are key players in the global kidney stone retrieval devices market, providing diagnosis, treatment, and post-operative care for patients with kidney stones. With advanced infrastructure and skilled medical professionals, they are preferred for complex surgical procedures like ureteroscopy, percutaneous nephrolithotomy, and ESWL. Hospitals offer a wide range of diagnostic imaging systems and treatment devices, including laser lithotripters and flexible ureteroscopes.

Moroever, they also conduct educational programs and training workshops to familiarize healthcare providers with the latest retrieval technologies. As kidney stone disease prevalence increases, hospitals expand their capacity to meet the growing patient load, boosting demand for kidney stone retrieval devices.

For instance, in October 2024, Osmania General Hospital in Hyderabad has acquired the first-of-its-kind Extracorporeal Shockwave Lithotripsy (ESWL) machine, providing a non-invasive solution for kidney stone removal. The machine was installed in the Urology Department under a Corporate Social Responsibility initiative by Mobis India Limited.

Geographical Analysis

North America is expected to hold a significant position in the Kidney Stone Retrieval Devices market share

North America holds a substantial position in the kidney stone retrieval devices market and is expected to hold most of the market share due to the increasing prevalence of kidney stones in the region, largely due to lifestyle factors such as poor diet, obesity, high salt intake, and a sedentary lifestyle. The aging population, particularly in the U.S. and Canada, is more prone to kidney-related issues, driving the demand for these devices. The North American healthcare system, with advanced infrastructure and high healthcare spending, supports the adoption of advanced kidney stone retrieval devices. High awareness about health and medical conditions drives the demand for minimally invasive and efficient treatments.

For instance, in November 2024, The FDA has granted de novo clearance to the Stone Clear device, which uses non-invasive ultrasound pulses to help patients pass residual kidney stone fragments post-lithotripsy. The device is designed to manage kidney stones in clinic settings without requiring anesthesia. The device is designed to reduce the burden of residual fragment stones in patients who are more likely to have complications, emergency department visits, or repeat procedures. The Stone Clear device provides patients with a reliable non-invasive option to reduce their burden while being fully awake.

Europe is growing at the fastest pace in the Kidney Stone Retrieval Devices market

Europe holds the fastest pace in the kidney stone retrieval devices market and is expected to hold most of the market share due to the aging population, increasing awareness of early detection and treatment, and the strong healthcare system. The region's rising healthcare expenditure and government initiatives also contribute to market growth. The focus on minimally invasive procedures and technological advancements in medical devices further drives the demand for these devices in Europe.

For instance, in June 2022, Hospital Clinic de Barcelona has introduced a new kidney stone surgery technique called Percutaneous Nephrolithotomy (PNL), which involves a percutaneous puncture in the lumbar region to access the inside of the kidney cavity. The procedure can lead to complications such as renal haemorrhage, renal haematoma infection, residual fragments, and urinoma, which are collections of extravasated urine from the urinary tract. The technique is coordinated by Dr. Juan Lopez, who is also the head of Urology Surgery.

Competitive Landscape

The major global players in the kidney stone retrieval devices market include Boston Scientific Corporation, Olympus Corporation, Becton, Dickinson and Company, Cook Medical, Coloplast Group, Dornier MedTech, Storz Medical AG, CR Bard Inc, Stryker Corporation, Karl Storz SE & Co. KG and among others.

Key Developments

  • In November 2024, EndoTheia, Inc. has completed the first-in-human clinical trial for the FlexStone Basket, the first-ever independently steerable kidney stone basket. The device offers unparalleled precision and control in kidney stone removal, making it a significant advancement in urological care. The trial was conducted at Vanderbilt University Medical Center by Nicholas Kavoussi and Ryan Hsi.
  • In August 2024, Calyxo, Inc., a medical device company, has released positive study results for its CVAC System in kidney stone clearance. The study found that healthcare consumption events, including emergency department visits, hospitalization, and retreatment, were significantly lower after steerable ureteroscopic renal evacuation (SURE) with the CVAC System compared to ureteroscopy (URS)

Emerging Players

The emerging players in the kidney stone retrieval devices market include Applaud Medical, Calyxo, Inc., Lumenis Ltd, DirexGroup, HealthTronics, Inc. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global kidney stone retrieval devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Treatment Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Treatment Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Kidney Stone Disease
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Skilled Professionals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Lithotripters*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Ureteroscopes
  • 6.4. Stone Removal Baskets
  • 6.5. Stone Removal Forceps
  • 6.6. Stents

7. By Treatment Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 7.1.2. Market Attractiveness Index, By Treatment Type
  • 7.2. Extracorporeal Shock Wave Lithotripsy*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Percutaneous Nephrolithotripsy
  • 7.4. Intracorporeal Ureteroscopy

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers (ASCs)
  • 8.4. Specialty Clinics

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Boston Scientific Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Olympus Corporation
  • 11.3. Becton, Dickinson and Company
  • 11.4. Cook Medical
  • 11.5. Coloplast Group
  • 11.6. Dornier MedTech
  • 11.7. Storz Medical AG
  • 11.8. CR Bard Inc
  • 11.9. Stryker Corporation
  • 11.10. Karl Storz SE & Co. KG

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us